National Cancer Registry Ireland
National Cancer Registry Ireland (NCRI) is Ireland's statutory population-based cancer registry, established in 1991, collecting and publishing comprehensive data on cancer incidence, survival, and mortality for the entire Irish population.
- Company typePrivate
- Founded1991
- HeadquartersCork, Ireland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What National Cancer Registry Ireland does
National Cancer Registry Ireland (NCRI) is Ireland's statutory population-based cancer registry, established by the Irish government in 1991 and operating its data-collection programme since 1994. NCRI collects, analyses, and disseminates comprehensive information on all cancer cases in Ireland — covering approximately 41,700 tumours and 9,800 cancer deaths per year (2020-2022 averages) — and serves as the authoritative national source for cancer incidence, survival, and mortality statistics used by the Health Service Executive, the Department of Health, academic researchers, clinicians, advocacy organisations (notably the Irish Cancer Society), and the general public.
NCRI's product surface comprises six core offerings: an interactive data dashboard for browsing and downloading cancer statistics; a publications programme (annual statistical reports, trend reports, factsheets, infographics, peer-reviewed articles); a structured custom data-request service; an EU-compliant open data portal; county-level cancer incidence maps; and a Secure Data Environment (SDE) launched in June 2026 in partnership with Aridhia. The SDE provides approved researchers with controlled, auditable access to anonymised or pseudonymised cancer data under FAIR data principles, and is positioned for alignment with the European Health Data Space. NCRI participates in European cancer-data initiatives including ENCR, ECIS, CancerWatch Joint Action, and Orion Joint Action.
As a publicly appointed state body, NCRI's revenue model is dominated by direct government funding allocations rather than commercial sales; core data access is free to all users, and revenue-generating activities are limited to commercial data-request fees (€100/hour), FOI internal review fees (€30 / €10 reduced), Information Commissioner review fees (€50 / €15 reduced), and capped search/retrieval charges (€20/hour, €0.04/sheet, ceiling €500-€700). The go-to-market motion is mandate-driven rather than sales-led: engagement is structured through open publication, webinars, European consortium participation, and earned media rather than commercial sales cycles.
National Cancer Registry Ireland firmographics
Firmographics- Name
- National Cancer Registry Ireland
- Legal name
- National Cancer Registry Ireland
- Website
- https://ncri.ie
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- National Cancer Registry Ireland (NCRI) is Ireland's statutory population-based cancer registry, established in 1991, collecting and publishing comprehensive data on cancer incidence, survival, and mortality for the entire Irish population.
- Ownership category
- akta.pro rank
National Cancer Registry Ireland industry classification
Industry- Product category
- Cancer Registry Services
- NAICS
- Information (51)
- akta.pro primary industry
- Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer) (HLAJANAG)
- akta.pro secondary industries
- Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI), Data Privacy, Confidentiality & Statistical Disclosure Control (HLAJAJAN), Data Governance, Standards & Interoperability (ICD, HL7/FHIR, LOINC, SNOMED) (HLAJAJAM)
Keywords
Where National Cancer Registry Ireland is headquartered
LocationHeadquarters
- HQ city
- Cork
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
National Cancer Registry Ireland business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations
Revenue model
- Government Funding: NCRI is a publicly appointed body established in 1991, funded through government allocations as a statutory body. Core operations are supported by public sector funding rather than commercial revenue generation.
- Data Request Fees: Charges of €100 per hour apply for commercial companies requesting data not routinely published by NCRI. FOI internal review fees of €30 (standard) or €10 (medical card holders) apply. Information Commissioner review fees are €50 (standard) or €15 (medical card holders/third parties). Search, retrieval and photocopying fees apply above €101 threshold, capped at €500 (or €700 upper limit).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free open data access for general public |
| Usage-based | Pay-as-you-go | Commercial data request fee |
| Unit Pricing | Pay-as-you-go | FOI internal review fee |
| Unit Pricing | Pay-as-you-go | Information Commissioner review fee |
| Unit Pricing | Pay-as-you-go | Search, retrieval and photocopying |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels8 records
National Cancer Registry Ireland product offering
Product offeringCore offering
National Cancer Registry Ireland (NCRI) is a statutory public body that collects, classifies, analyses, and disseminates comprehensive population-based cancer data for Ireland. Its core offerings include interactive data dashboards, cancer incidence and survival statistics, annual statistical reports, cancer factsheets, downloadable incidence maps, open data, a formal data request service for custom queries, and a Secure Data Environment (SDE) for approved researcher access to anonymised individual-level cancer data.
Product overview
National Cancer Registry Ireland operates as a public health data collection and reporting organization rather than a traditional software company. Its product portfolio centers on cancer surveillance data services, comprising an interactive data dashboard for browsing and downloading cancer statistics, published reports and publications (including annual statistical reports, cancer trend reports, factsheets, and infographics), a data request service for custom data queries, an open data initiative compliant with EU Open Data Directive, interactive cancer incidence maps at county level, and a Secure Data Environment (SDE) delivered in partnership with Aridhia for secure researcher access to sensitive cancer data. The offerings range from freely accessible public statistics to controlled-access research platforms, serving public health officials, researchers, clinicians, and the general public.
Differentiator
Problem solved
Functional benefit
Products and services
- Interactive Data Dashboard
Quantifiable outcome
- Cancer diagnosis data collected for an average of 41,700 tumours per year (2020-2022), with national coverage of all cancer cases in Ireland
- +6 more outcomes
Companies that use National Cancer Registry Ireland
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
National Cancer Registry Ireland technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
National Cancer Registry Ireland partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AridhiacoreNCRI partnered with Aridhia to deliver a Secure Data Environment (SDE) for cancer research in Ireland. The SDE provides approved researchers with access to anonymised or pseudonymised cancer data within a secure, controlled digital setting. Aridhia brings advanced technology and expertise supporting a modern, scalable infrastructure for secure research collaboration. The initiative represents a significant step forward in how sensitive health data is accessed and used for research in Ireland.
Scale indicators12 records
Recent moves6 records
Expansion highlights5 records
National Cancer Registry Ireland competitors and assessment
Company assessmentBroad incumbents
- National Cancer Institute (NCI): The US federal government's principal agency for cancer research and surveillance (via its SEER program). Directly comparable as a national-level statutory cancer data and research authority, though far larger and operating across research, treatment, and policy.
- International Agency for Research on Cancer (IARC): WHO's specialised cancer research agency that coordinates global cancer surveillance (CI5, GLOBOCAN) and hosts the European Network of Cancer Registries (ENCR) that NCRI participates in. Comparable as the international coordinating body for cancer registry data and methods.
Direct peers
- National Cancer Registration and Analysis Service (NCRAS), NHS England: England's population-based cancer registry within NHS Digital. Most direct functional peer to NCRI — collects, analyses, and disseminates cancer incidence, survival, and treatment data for the entire English population, with similar statutory mandate and European comparability.
- Swedish National Cancer Registry: One of the world's oldest population-based cancer registries (since 1958), operated by Sweden's National Board of Health and Welfare. Comparable scope (national coverage, statutory mandate) and co-participation in European cancer data networks (ENCR, ECIS).
- Cancer Registry of Norway: Norway's population-based cancer registry with national coverage, statutory mandate, and active role in Nordic and European cancer data collaboration. Operates at similar organisational scale and shares NCRI's ENCR/ECIS integration.
- Canadian Cancer Registry (Statistics Canada): Statistics Canada's national cancer registry that compiles population-level incidence and survival data from provincial registries. Comparable as a federally-coordinated population cancer surveillance system, with similar mandate to support research and policy.
- Australian Institute of Health and Welfare (AIHW) — Cancer Database: Australia's national cancer statistics authority (under AIHW), covering incidence, mortality, and survival for the entire Australian population. Comparable as a publicly-funded national cancer surveillance body with similar data dissemination functions.
Others
- European Cancer Information System (ECIS): JRC-operated European cancer data dissemination platform to which NCRI contributes Ireland's data. Comparable as the supranational aggregation/distribution layer that NCRI feeds into, and a key benchmark for cross-country cancer indicator reporting.
- Aridhia: Health-data analytics platform provider that partnered with NCRI in 2026 to deliver its Secure Data Environment. Comparable as the technology ecosystem partner enabling NCRI's secure researcher-access platform and similar SDE deployments for other public-sector health bodies.
Regional players
- Irish Health Service Executive (HSE): Ireland's national health service delivery body and primary NCRI customer. Not a registry peer in the strict sense, but a critical institutional partner for cancer data — comparable as the principal downstream consumer of NCRI's surveillance data for service planning and policy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
National Cancer Registry Ireland social profiles
Digital presenceNational Cancer Registry Ireland compliance and trust
Trust signalCompliance2 records
National Cancer Registry Ireland financial estimates
Financial estimateRevenue estimate
Valuation estimate
National Cancer Registry Ireland leadership team
Management profileNumber of profiles
Profiles6 records
National Cancer Registry Ireland funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
National Cancer Registry Ireland M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about National Cancer Registry Ireland
What does National Cancer Registry Ireland do?
National Cancer Registry Ireland (NCRI) is a statutory public body that collects, classifies, analyses, and disseminates comprehensive population-based cancer data for Ireland. Its core offerings include interactive data dashboards, cancer incidence and survival statistics, annual statistical reports, cancer factsheets, downloadable incidence maps, open data, a formal data request service for custom queries, and a Secure Data Environment (SDE) for approved researcher access to anonymised individual-level cancer data.
Is National Cancer Registry Ireland a public or private company?
National Cancer Registry Ireland is a private company. It is classified as state government owned and is currently operating.
When was National Cancer Registry Ireland founded?
National Cancer Registry Ireland was founded in 1991. It employs 11 to 50 people.
Where is National Cancer Registry Ireland based?
National Cancer Registry Ireland is headquartered in Cork, Ireland, in the Europe region.
How does National Cancer Registry Ireland make money?
Two revenue lines are on record. Government Funding is the primary driver. The others are data Request Fees.
Who are National Cancer Registry Ireland's main competitors?
Broad incumbents on record are National Cancer Institute (NCI) and International Agency for Research on Cancer (IARC). Direct peers are National Cancer Registration and Analysis Service (NCRAS), NHS England, Swedish National Cancer Registry, Cancer Registry of Norway, Canadian Cancer Registry (Statistics Canada) and Australian Institute of Health and Welfare (AIHW) — Cancer Database. Others are European Cancer Information System (ECIS) and Aridhia. Irish Health Service Executive (HSE) is listed as a regional player.
Does National Cancer Registry Ireland have an API?
No public API is recorded for National Cancer Registry Ireland.
What industry is National Cancer Registry Ireland in?
National Cancer Registry Ireland's product category is Cancer Registry Services. Its primary akta.pro industry code is HLAJANAG, Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer), with a secondary code of BPAIAJAI, Non-Communicable Disease Prevention & Chronic Disease Programs. Its NAICS code is 51.